Zhongyi Sun

Dr. Zhongyi Sun


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2024 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
FZFanchun Zeng
Fanchun Zeng
QCQuanfu Cao
Quanfu Cao
FFFengwen Fu
Fengwen Fu
BWBin Wang
Bin Wang
ZSZhongyi Sun
Zhongyi Sun

6 February 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZFZeng Fanchun
Zeng Fanchun
YCYuan Chen
Yuan Chen
MGMinggan Guo
Minggan Guo
FFFengwen Fu
Fengwen Fu
QCQuanfu Cao
Quanfu Cao
ZSZhongyi Sun
Zhongyi Sun
Bladder rupture repair surgery is limited by its long duration, significant blood loss, and complex procedures. Biological welding technology, which integrates multiple functions such as cutting, hemostasis, and tissue fusion, has shown potential in the field of soft tissue repair surgery but has not yet been widely explored in clinical applications for bladder rupture repair. This study used 32 adult male Beagle dogs to establish a bladder rupture model, randomly assigned to the biological welding group or the traditional suturing group. Outcomes assessed included surgical time, blood loss, postoperative inflammation, and hematuria. Histopathological analysis and RNA sequencing analysis were performed at multiple postoperative time points to evaluate the tissue recovery process and repair mechanisms. The results demonstrated that biological welding significantly reduced surgical time (21.80 ± 4.79 min vs. 75.15 ± 13.26 min, p < 0.001) and intraoperative blood loss (6.37 ± 0.89 g vs. 30.36 ± 6.59 g, p < 0.001) compared to traditional suturing. Postoperative complications, such as hematuria and inflammatory response, were notably lower in the biological welding group. Histopathological analysis revealed enhanced cell migration and tissue fusion in the biological welding group, leading to accelerated bladder healing and reduced adhesions. Transcriptomic sequencing indicated that biological welding activated a limited number of immune-related genes and signaling pathways in the early postoperative period, facilitating rapid repair and a shorter duration of abnormal gene expression. Our research indicates that biological welding technology demonstrates significant advantages in bladder rupture repair surgery, including enhanced surgical efficiency, reduced incidence of postoperative complications, and accelerated tissue healing process, with broad prospects for clinical application.

22 July 2026 in International Journal of Bioprinting
Verified
Journal Article
Open access
PDF file
YCYuan Chen
Yuan Chen
SYShuheng Yang
Shuheng Yang
JCJiaqi Chen
Jiaqi Chen
MGMinggan Guo
Minggan Guo
YLYahan Li
Yahan Li
ZFZeng Fanchun
Zeng Fanchun
Three-dimensional (3D) bioprinting has advanced rapidly, but clinical translation of orthopedic grafts remains constrained by a mismatch between printable constructs and indication-specific failure modes. Bone, cartilage, and osteochondral defects impose distinct requirements: vascularized remodeling and load sharing for bone, phenotypic stability and low-friction durability for cartilage, and mechanically integrated compartmental organization for osteochondral repair. This narrative review synthesizes recent evidence on 3D-bioprinted orthopedic grafts with a translational focus on design specifications, validation endpoints, manufacturing control, and regulatory readiness. Rather than treating bioinks, printing platforms, and cell sources as isolated technologies, the review organizes them according to clinical function: structural support, biological instruction, process control, maturation, immune compatibility, and product qualification. Current evidence indicates that many constructs remain validated mainly by early biological markers, representative imaging, or short-term animal outcomes, whereas clinically relevant tests of fatigue, wear, degradation-coupled mechanics, host–graft integration, vascular perfusion, immune response, sterility, dimensional tolerances, and release criteria are less consistently reported. Near-term translation appears most plausible for acellular or minimally cellular reinforced constructs, patient-specific but quality-testable bone scaffolds, and selected intraoperative applications with clear surgical utility. More complex living grafts that combine vascular, immune-instructive, and multi-tissue functions will require stronger preclinical models, standardized reporting, and product-specific regulatory strategies. Translation in orthopedic bioprinting should begin with the clinical failure mode and proceed toward measurable release specifications, not with printability alone.